c.315+11C>T
SpliceS3Likely benignCytoplasmic · predictedS3 — Minimal predicted splicing impact (SpliceAI ΔS 0.00)
Interactive 3D Structure
AlphaFold wild-type wolframin · the variant site near residue 105 (N-terminal cytoplasmic (intrinsically disordered)) is highlighted.
Variant Assessment
Therapeutic Implication · S3
Clinical Evidence
Observed at very low frequency in gnomAD.
ClinVar classifies this variant as Benign/Likely benign for Nonsyndromic hearing loss (DFNA6/14/38) (autosomal dominant, OMIM 600965); WFS1-related spectrum (unresolved mode) (dominant or recessive); Wolfram syndrome (classic) (autosomal recessive, OMIM 222300). ClinVar records this under a WFS1-spectrum label that spans both disease families — recessive Wolfram syndrome (biallelic) and the dominant WFS1-related disorders. The label does not resolve which applies, and it is not a severity statement.
- Nonsyndromic hearing loss (DFNA6/14/38)autosomal dominant · OMIM 600965submitted as: Autosomal dominant nonsyndromic hearing loss 6
- WFS1-related spectrum (unresolved mode)dominant or recessivesubmitted as: WFS1-Related Spectrum Disorders
- Wolfram syndrome (classic)autosomal recessive · OMIM 222300submitted as: Wolfram syndrome 1
- Phenotype scope is interpretation of submitted records. The computed values on this card (AlphaMissense, DynaMut2 ΔΔG, pLDDT) are measurements of the model, not of a patient.
- Presentation cannot be generalised from neighbouring variants: one nucleotide over can present very differently. Structural similarity supports a mechanistic hypothesis, never a phenotype claim.
Review status: 2★ multiple submitters, no conflicts. ClinVar "conditions" is the union of all submissions; 0–1★ entries are submitted conditions, not documented phenotypes.
Highest in East Asian: AF 0.026% (11 of 41,872 alleles), 9.5x the global figure. The global AF describes the general population, not the at-risk group.
No homozygotes reported in gnomAD v4. For a recessive allele this is expected and is not, on its own, evidence either way.
| Ancestry group | Allele freq. | AC / AN | Hom. | Carrier est. |
|---|---|---|---|---|
| East Asian | 0.026% | 11 / 41,872 | 0 | ~1 in 1900 |
| Admixed American | 0.016% | 8 / 51,076 | 0 | ~1 in 3190 |
| South Asian | 0.0071% | 6 / 84,364 | 0 | ~1 in 7030 |
| Remaining individuals | 0.0033% | 2 / 60,158 | 0 | ~1 in 15040 |
| African / African American · under-sampled | 0.0014% | 1 / 73,668 | 0 | — |
| European (non-Finnish) | 0.0013% | 15 / 1,147,810 | 0 | ~1 in 38260 |
Source: gnomAD r4, retrieved 2026-08-21. Values are allele frequencies. The carrier estimate is derived from the allele frequency (Hardy-Weinberg, ~2·AF) and is an approximation, not a published figure — where a published carrier frequency exists it outranks this column and is cited on the card.
Feed this card to Wolfram Intelligence
Download the c.315+11C>T card below and upload it to Wolfram Intelligence to generate therapeutic-strategy proposals matched to this S3 splice variant and its domain context.
Full Variant Card
c.315+11C_T — WFS1 Molecular Atlas Card
Variant type: Splice site Boundary: donor (5' splice site) · intronic offset +11 Nearest protein position: ~105 (N-terminal cytoplasmic (intrinsically disordered))
Schema category: S3 — Minimal predicted splicing impact (SpliceAI ΔS 0.00)
SpliceAI predicts little splicing disruption at this donor (5') site (max ΔS 0.00 < 0.2; acceptor-gain 0.00, acceptor-loss 0.00, donor-gain 0.00, donor-loss 0.00). The variant may be tolerated or act through a weak/again-tissue-specific mechanism; wet-lab RNA validation is the arbiter before any therapeutic call.
Splice prediction
- Affected site: donor (5' splice site), extended splice region
- SpliceAI delta scores (GRCh38 chr4:6287186 C>T):
- acceptor gain 0.00 · acceptor loss 0.00
- donor gain 0.00 · donor loss 0.00
- Predicted outcome: Minimal predicted splicing impact (SpliceAI ΔS 0.00)
Clinical evidence
Inheritance and scope
Benign/Likely benign — for Nonsyndromic hearing loss (DFNA6/14/38) (autosomal dominant, OMIM 600965); WFS1-related spectrum (unresolved mode) (dominant or recessive); Wolfram syndrome (classic) (autosomal recessive, OMIM 222300)
ClinVar classifies this variant as Benign/Likely benign for Nonsyndromic hearing loss (DFNA6/14/38) (autosomal dominant, OMIM 600965); WFS1-related spectrum (unresolved mode) (dominant or recessive); Wolfram syndrome (classic) (autosomal recessive, OMIM 222300). ClinVar records this under a WFS1-spectrum label that spans both disease families — recessive Wolfram syndrome (biallelic) and the dominant WFS1-related disorders. The label does not resolve which applies, and it is not a severity statement.
Phenotype scope is interpretation of submitted records. The computed values on this card (AlphaMissense, DynaMut2 ΔΔG, pLDDT) are measurements of the model, not of a patient. Presentation cannot be generalised from neighbouring variants: one nucleotide over can present very differently. Structural similarity supports a mechanistic hypothesis, never a phenotype claim.
- Classification: Benign/Likely benign
- Review status: criteria provided, multiple submitters, no conflicts
- Associated conditions: Autosomal dominant nonsyndromic hearing loss 6; WFS1-Related Spectrum Disorders; Wolfram syndrome 1
- cDNA change: c.315+11C>T
- ClinVar accession: VCV000349311
- Last evaluated: 2026/01/05 00:00
- Submissions: 1
Card generated by wolfram-atlas-batch (splice pipeline) on 2026-06-08T07:49:51.998247Z.
Schema: reference/card_schema_extension.md (S1–S3). WFS1: UniProt O76024, AlphaFold v6.